Risk prediction model for cardiovascular and cerebrovascular event development in systemic lupus erythematosus (SLE)
| Predictors | HR (95% CI) | Beta coefficient | P value |
| Age of SLE onset >40 | 4.148 (2.712 to 6.345) | 1.423 | <0.001 |
| Anti-β2GP1 | 2.695 (1.565 to 4.640) | 0.991 | <0.001 |
| Smoking | 2.453 (1.152 to 5.224) | 0.897 | 0.02 |
| High-dose glucocorticoids | 2.101 (1.22 to 3.618) | 0.743 | 0.0074 |
| Male gender | 1.888 (1.041 to 3.423) | 0.635 | 0.036 |
| Hypertension | 1.852 (1.133 to 3.027) | 0.616 | 0.014 |
| HCQ usage | 0.578 (0.381 to 0.878) | −0.548 | 0.01 |
| Cutaneous involvement | 0.504 (0.286 to 0.887) | −0.685 | 0.017 |
| Arthritis | 0.435 (0.253 to 0.749) | −0.832 | 0.0027 |
HCQ, hydroxychloroquine.